サウスカロライナにおける乳がんの臨床試験
サウスカロライナ内の拠点で、乳がんに関する23件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Bon Secours St Francis Cancer Center, Greenville
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/10/02更新 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- 他12件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069CBD for Breast Cancer Primary Tumors
- Medical University of South Carolina, Charleston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06148038A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Medical University of South Carolina-Hollings Cancer Center ( Site 0016), Charleston
- St Francis Cancer Center ( Site 0093), Greenville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06966700The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- St. Joseph's Candler Bluffton Campus, Bluffton
- SC Cancer Specialists - Hilton Head at St. Joseph's/Candler, Hilton Head Island
- Levine Cancer Institute, Rock Hill
被験者募集中第3相
60歳以上 · 全性別 · 2026/09/25更新 · NCT06377852A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Medical University of South Carolina, Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Hollings Cancer Center, Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT06492616Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Spartanburg Regional Healthcare System, Spartanburg
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT05315700A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Bon Secours - St. Francis Hospital, Greenville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06790693Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Medical University of South Carolina, Charleston
- 他14件
被験者募集中第3相
18歳〜60歳 · 女性 · 2026/09/02更新 · NCT05879926A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- St Francis Cancer Center, Greenville
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06926868E-Mindfulness Approaches for Living After Breast Cancer
- Beaufort Memorial Hospital, Beaufort
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Medical University of South Carolina, Charleston
- 他10件
被験者募集中第3相
18歳〜50歳 · 全性別 · 2026/08/04更新 · NCT06748222Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
- Medical University of South Carolina, Charleston
被験者募集中第2相
18歳〜55歳 · 女性 · 2026/07/27更新 · NCT06184750Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
- Prisma Health - Upstate (ITOR)_Edenfield ( Site 0053), Greenville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06686394Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Medical University of South Carolina, Charleston
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/29更新 · NCT04468061De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Medical University of South Carolina, Charleston
- McLeod Regional Medical Center, Florence
- 他5件
被験者募集中第3相
50歳〜70歳 · 全性別 · 2026/04/23更新 · NCT04852887Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- AnMed Health Cancer Center, Anderson
- Beaufort Memorial Hospital, Beaufort
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- 他18件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Spartanburg Medical Center, Spartanburg
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/20更新 · NCT06401421cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Prisma Health Cancer Institute - Butternut, Greenville
- Prisma Health Cancer Institute - Faris, Greenville
- Prisma Health Cancer Institute - Eastside, Greenville
被験者募集中第3相
18歳以上 · 全性別 · 2025/10/08更新 · NCT03418961MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Roper St. Francis Physician Partners - Breast Surgery, Charleston
- Tidelands Health Coastal Carolina Breast Center, Georgetown
被験者募集中観察研究
18歳以上 · 全性別 · 2025/08/20更新 · NCT03053193Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients
- Prisma Health Cancer Institute, Greenville
被験者募集中観察研究
20歳以上 · 女性 · 2024/11/04更新 · NCT06672497ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。